Here's What Key Metrics Tell Us About DXC Technology (DXC) Q2 Earnings

For the quarter ended September 2025, DXC Technology Company. (DXC) reported revenue of $3.16 billion, down 2.5% over the same period last year. EPS came in at $0.84, compared to $0.93 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $3.18 billion, representing a surprise of -0.58%. The company delivered an EPS surprise of +18.31%, with the consensus EPS estimate being $0.71.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how DXC Technology performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Total Revenues - YoY change: -2.5% compared to the -1.9% average estimate based on three analysts.Global Infrastructure Services (GIS) - YoY change: -4.2% versus -1% estimated by three analysts on average.Revenues- Global Infrastructure Services (GIS): $1.59 billion versus the three-analyst average estimate of $1.58 billion. The reported number represents a year-over-year change of +1.7%.View all Key Company Metrics for DXC Technology here>>>Shares of DXC Technology have returned -4.6% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report DXC Technology Company. (DXC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks